Australian politicians have reacted to U.S. President Donald Trump’s directive to introduce 100 percent tariffs on pharmaceutical imports on Oct. 1.
Australia is a major exporter of blood and plasma products to America valued at A$2 billion last year.
“Starting October 1st, 2025, we will be imposing a 100 percent tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufacturing plant in America,” Trump wrote on Truth Social.
“’Is building’ will be defined as ‘breaking ground’ and/or ‘under construction.’
“There will, therefore, be no tariff on these pharmaceutical products if construction has started.”
While Prime Minister Anthony Albanese has a face-to-face meeting planned with Trump for Oct. 20, the Coalition expressed concerned not enough had been done to negotiate the U.S. tariffs….